Year To Quarter End Statement Of Income

KAKEN PHARMACEUTIAL CO., LTD. - Filing #7721245

Concept 2018-04-01 to
2018-06-30
2018-04-01 to
2018-06-30
2018-04-01 to
2018-06-30
2018-04-01 to
2018-06-30
2018-04-01 to
2018-06-30
2017-04-01 to
2017-06-30
2017-04-01 to
2017-06-30
2017-04-01 to
2017-06-30
2017-04-01 to
2017-06-30
2017-04-01 to
2017-06-30
Year to quarter end statement of income
Statement of income
Net sales
24,135,000,000 JPY
583,000,000 JPY
23,551,000,000 JPY
JPY
24,135,000,000 JPY
24,967,000,000 JPY
24,967,000,000 JPY
599,000,000 JPY
24,367,000,000 JPY
JPY
Cost of sales
10,167,000,000 JPY
10,520,000,000 JPY
Gross profit (loss)
13,967,000,000 JPY
14,447,000,000 JPY
Selling, general and administrative expenses
8,319,000,000 JPY
6,798,000,000 JPY
Selling, general and administrative expenses
Salaries
1,741,000,000 JPY
1,805,000,000 JPY
Operating profit (loss)
5,647,000,000 JPY
369,000,000 JPY
5,278,000,000 JPY
JPY
5,647,000,000 JPY
7,649,000,000 JPY
7,649,000,000 JPY
414,000,000 JPY
7,234,000,000 JPY
JPY
Non-operating income
Interest income
1,000,000 JPY
0 JPY
Dividend income
179,000,000 JPY
170,000,000 JPY
Non-operating income
186,000,000 JPY
179,000,000 JPY
Non-operating expenses
Interest expenses
4,000,000 JPY
4,000,000 JPY
Non-operating expenses
16,000,000 JPY
15,000,000 JPY
Ordinary profit (loss)
5,817,000,000 JPY
7,813,000,000 JPY
Extraordinary losses
Extraordinary losses
34,000,000 JPY
33,000,000 JPY
Profit (loss) before income taxes
5,782,000,000 JPY
7,780,000,000 JPY
Income taxes
1,747,000,000 JPY
2,317,000,000 JPY
Profit (loss)
4,035,000,000 JPY
5,463,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.